GenEditBio Limited

📍 Hong Kong, Hong Kong SAR🗓 Founded 2021👥 22 employees💰 Last funded 2021
Biotechnology Research🌐 geneditbio.com
Website LinkedIn
Established in 2021 and headquartered in Hong Kong, China, GenEditBio is a gene therapy start-up company with an overarching strategic goal of providing potentially curative, once-and-done and programmable in vivo genome editing-based therapeutic solutions (dubbed “DNA surgery”) with high safety profile, unmatched precision, and affordable access for genetic diseases with unmet needs. The Company’s core areas of focus include novel Cas nuclease discovery and safe and efficient cargo delivery utilizing lipid nanoparticle (LNP) and engineered protein delivery vehicle (PDV). We have research laboratories and supporting offices in Hong Kong, Beijing, and Boston.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
China
1
Frequently asked questions
Who invested in GenEditBio Limited?
GenEditBio Limited has 1 investors on record on gritt.io, including 1 early-stage backers.
When did GenEditBio Limited last raise funding?
The most recent investment in GenEditBio Limited recorded on gritt.io was in 2021.
When was GenEditBio Limited founded?
GenEditBio Limited was founded in 2021.
What industry is GenEditBio Limited in?
GenEditBio Limited operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is GenEditBio Limited based?
GenEditBio Limited is headquartered in Hong Kong, Hong Kong SAR.